Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Davidson, MD
Northwestern University
Principal Investigator - Richard Solomon, MD
University of Vermont
Principal Investigator - Roxana Mehran, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Torrance Medical Center
Torrance, California, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Clearwater Cardiovascular
Clearwater, Florida, United States
- University of Florida
Jacksonville, Florida, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- Advocate Good Samaritan
Downers Grove, Illinois, United States
- Advocate Health
Naperville, Illinois, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- St. Elizabeth'S Hospital
Brighton, Massachusetts, United States
- Cape Cod Healthcare
Hyannis, Massachusetts, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- Northern Michigan Hospital
Petoskey, Michigan, United States
- Abbott Northwestern
Minneapolis, Minnesota, United States
- North Mississippi Medical Center
Tupelo, Mississippi, United States
- St. Joseph Medical Center
Saint Charles, Missouri, United States
- Columbia University
New York, New York, United States
- Montefiore Medical Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- Nyu Medical Center
New York, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Rex Hospital
Raleigh, North Carolina, United States
- St. John Research Institute
Bartlesville, Oklahoma, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Guthrie Medical Center
Sayre, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- the Miriam Hospital
Providence, Rhode Island, United States
- Austin Heart Central
Austin, Texas, United States
- Baylor Scott & White
Plano, Texas, United States
- Austin Heart Round Rock
Round Rock, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2012
- Primary completion
- 31 Mar 2018
- Completion
- 31 Dec 2024
- Last update posted
- 16 Feb 2023
- Registered enrollment
- 326
- Registry id
- NCT01456013
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.